AI assistant
Sending…
Climb Bio, Inc. — Director's Dealing 2025
Apr 1, 2025
33982_dirs_2025-04-01_0db43609-a056-458b-89bf-b4b6e0e4ff53.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Climb Bio, Inc. (CLYM)
CIK: 0001768446
Period of Report: 2025-03-28
Reporting Person: Cumbo Alexander (N/A)
More from Climb Bio, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Director's Dealing
2026
Feb 27
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8